106 related articles for article (PubMed ID: 8167713)
21. The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.
Aruffo A; Hollenbaugh D; Wu LH; Ochs HD
Curr Opin Hematol; 1994 Jan; 1(1):12-8. PubMed ID: 9371254
[TBL] [Abstract][Full Text] [Related]
22. Autosomal dominant mutations affecting X inactivation choice in the mouse.
Percec I; Plenge RM; Nadeau JH; Bartolomei MS; Willard HF
Science; 2002 May; 296(5570):1136-9. PubMed ID: 12004136
[TBL] [Abstract][Full Text] [Related]
23. Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis.
Puck JM; Krauss CM; Puck SM; Buckley RH; Conley ME
N Engl J Med; 1990 Apr; 322(15):1063-6. PubMed ID: 2320067
[No Abstract] [Full Text] [Related]
24. Haemophilia B in female twins caused by a point mutation in one factor IX gene and nonrandom inactivation patterns of the X-chromosomes.
Schröder W; Wulff K; Wollina K; Herrmann FH
Thromb Haemost; 1997 Nov; 78(5):1347-51. PubMed ID: 9408017
[TBL] [Abstract][Full Text] [Related]
25. Further linkage evidence for localization of mutational sites for nonsyndromic types of X-linked mental retardation at the pericentromeric region.
Robledo R; Melis P; Laficara F; Marchi J; Rinaldi A; Siniscalco M; Filippi G
Am J Med Genet; 1996 Jul; 64(1):107-12. PubMed ID: 8826459
[TBL] [Abstract][Full Text] [Related]
26. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.
Santisteban I; Arredondo-Vega FX; Kelly S; Mary A; Fischer A; Hummell DS; Lawton A; Sorensen RU; Stiehm ER; Uribe L
J Clin Invest; 1993 Nov; 92(5):2291-302. PubMed ID: 8227344
[TBL] [Abstract][Full Text] [Related]
27. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
[TBL] [Abstract][Full Text] [Related]
28. Partial immune reconstitution after bone marrow transplantation in a boy with recombination activating gene 1 defect.
Muñoz-Robles J; Del Rey MJ; Ruiz-Contreras J; Clemente J; Ramos JT; Paz-Artal E; Allende LM
Bone Marrow Transplant; 2004 Apr; 33(8):877-8. PubMed ID: 14990985
[No Abstract] [Full Text] [Related]
29. Gene therapy of severe combined immunodeficiencies.
Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a new locus for X-linked retinitis pigmentosa (RP23).
Hardcastle AJ; Thiselton DL; Zito I; Ebenezer N; Mah TS; Gorin MB; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2080-6. PubMed ID: 10892847
[TBL] [Abstract][Full Text] [Related]
31. Linkage analysis in three families with nonspecific X-linked mental retardation.
Claes S; Gu XX; Legius E; Lorenzetti E; Marynen P; Fryns JP; Cassiman JJ; Raeymaekers P
Am J Med Genet; 1996 Jul; 64(1):137-46. PubMed ID: 8826464
[TBL] [Abstract][Full Text] [Related]
32. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
33. Genetic approaches to isolating the genes for the X-linked immunodeficiencies.
Conley ME
Immunodeficiency; 1993; 4(1-4):203-7. PubMed ID: 8167701
[No Abstract] [Full Text] [Related]
34. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
[TBL] [Abstract][Full Text] [Related]
35. Genetic mosaicism: what Gregor Mendel didn't know.
Hirschhorn R
J Clin Invest; 1995 Feb; 95(2):443-4. PubMed ID: 7860724
[No Abstract] [Full Text] [Related]
36. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics.
Jones JF; Ritenbaugh CK; Spence MA; Hayward A
Hum Biol; 1991 Oct; 63(5):669-82. PubMed ID: 1916741
[TBL] [Abstract][Full Text] [Related]
37. X chromosome inactivation patterns in haematopoietic cells of female carriers of X-linked severe combined immunodeficiency determined by methylation analysis at the hypervariable DXS255 locus.
Hendriks RW; Kraakman ME; Schuurman RK
Clin Genet; 1992 Sep; 42(3):114-21. PubMed ID: 1395081
[TBL] [Abstract][Full Text] [Related]
38. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency.
Puck JM; Stewart CC; Nussbaum RL
Am J Hum Genet; 1992 Apr; 50(4):742-8. PubMed ID: 1550118
[TBL] [Abstract][Full Text] [Related]
39. Significant lone daughters and mutations in sex linkage risk estimations--a comprehensive computer programme.
Sit KH; Wong HB
Singapore Med J; 1986 Oct; 27(5):374-83. PubMed ID: 3823938
[No Abstract] [Full Text] [Related]
40. Trisomy X in a female member of a family with X linked severe combined immunodeficiency: implications for carrier diagnosis.
Lester T; de Alwis M; Clark PA; Jones AM; Katz F; Levinsky RJ; Kinnon C
J Med Genet; 1994 Sep; 31(9):717-20. PubMed ID: 7815443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
